Utility:
| Anti-B2GPI-D1 IgG are present more frequently and in higher titers in APS patients with thrombotic complications than in those without. QUANTA Flash B2GP1 Domain 1 chemiluminescence assay appears to be superior to full-length B2GPI assays for the risk assessment of thrombotic events in APS patients |